Cost Quality Campaign

Everything you need to make the Right Choice in healthcare.

Learn More →
 

ACO Results

2015 REPORTING PERIOD QUALITY MEASURE RESULTS AND COMPARISONS

The lower the percentage is the better the performance

Measure Name

Wilmington Health Rest of USA

Risk Standardized, All Condition Readmission

14.34% 14.86%

Skilled Nursing Facility 30-day All-Cause Readmission measure (SNFRM)

17.48% 18.07%

All-Cause Unplanned Admissions for Patients with Diabetes

49.88% 54.60%

All-Cause Unplanned Admissions for Patients with Heart Failure

71.81% 

76.95%

All-Cause Unplanned Admissions for Patients with Multiple Chronic Conditions

59.27%

62.91%

Ambulatory Sensitive Condition Admissions: Chronic Obstructive Pulmonary Disease or Asthma in Older Adults (AHRQ Prevention Quality Indicator (PQI) #5)

0.89% 1.11%

Ambulatory Sensitive Conditions Admissions: Heart Failure (AHRQ Prevention Quality Indicator (PQI) #8)

0.98%  1.04%

Depression Remission at Twelve Months 

0% 6.11%

Diabetes Mellitus: Hemoglobin A1c Poor Control

35.92% 20.38%

The higher percentage the better the performance

Measure Name

 Wilmington Health Rest of USA

CAHPS: Getting Timely Care, Appointments, and Information

79.00% 80.61%

CAHPS: How Well Your Providers Communicate

93.81% 92.65%

CAHPS: Patients’ Rating of Provider

92.88% 91.94%

CAHPS: Access to Specialists

85.18%

83.61%

AHPS: Health Promotion and Education 63.67% 59.06%
     
CAHPS: Shared Decision Making 73.31% 75.17%
     
CAHPS: Health Status/Functional Status 73.42% 72.3% 
     

CAHPS: Stewardship of Patient Resources  

27.56% 26.87%
Percent of PCPs who Successfully Meet Meaningful Use Requirements  95.12% 76.22%
     
Documentation of Current Medications in the Medical Record 91.95%  84.07%
     
Falls: Screening for Future Fall Risk 75.89% 56.46%
     
Preventive Care and Screening: Influenza Immunization 72.41% 62.03% 
     
Pneumonia Vaccination Status for Older Adults 85.77% 63.73%
     
Preventive Care and Screening: Body Mass Index (BMI) Screening and Follow-Up 92.36% 71.15%
     
Preventive Care and Screening: Tobacco Use: Screening and Cessation Intervention 99.31% 90.16% 
     
Preventive Care and Screening: Screening for Clinical Depression and Follow-up Plan 62.3% 45.25%
     
Colorectal Cancer Screening 83.33% 60.06%
     
Breast Cancer Screening 83.61% 65.67% 
     
Preventive Care and Screening: Screening for High Blood Pressure and Follow-Up Documented 86%  70.04%
     
Diabetes: Eye Exam  37.68% 41.05% 
     
Hypertension: Controlling High Blood Pressure 70.07% 69.62
     
Ischemic Vascular Disease: Use of Aspirin or Another Antithrombotic 84.68%  83.82%
     
Heart Failure: Beta-Blocker Therapy for Left Ventricular Systolic Dysfunction (LVSD) 93.08% 87.22%
     
Angiotensin-Converting Enzyme (ACE) Inhibitor or Angiotensin Receptor Blocker (ARB) Therapy - for patients with CAD and Diabetes or Left Ventricular Systolic Dysfunction (LVEF<40%) 76.38% 77.73%

 

CAHPS = Consumer Assessment of Healthcare Providers and Systems
PQI = Prevention Quality Indicator
LVSD = left ventricular systolic dysfunction
ACE = angiotensen-converting enyzme
ARB = angiotensin receptor blocker
CAD = coronary artery disease.

* = Measure required beginning Reporting Year 2015.
N/A = Reporting on the depression remission measure is not required for 2015, as indicated by N/A